A landmark case–control study of 46,958 Japanese individuals (17,752 stroke patients and 29,206 controls) provided compelling evidence for this expanded phenotype: RNF213 p.R4810K nearly doubled the overall ischemic stroke risk [odds ratio (OR) ~1.9] and increased LAA stroke risk by more than threefold. Here, RNF213 is linked to stroke disorder.